{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:59:44Z","timestamp":1790258384152,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA050607"],"award-info":[{"award-number":["K12DA050607"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RM1DA055311"],"award-info":[{"award-number":["RM1DA055311"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"DOI":"10.1186\/s13011-026-00746-1","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:08:28Z","timestamp":1783080508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perspectives on harm reduction kit implementation in heterogeneous outpatient clinics"],"prefix":"10.1186","volume":"21","author":[{"given":"Raagini","family":"Jawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Markus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Luiggi-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor de Abril","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"McMurtrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Studnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Check","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Liebschutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"2","key":"746_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","volume":"110","author":"TJ Cicero","year":"2020","unstructured":"Cicero TJ, Ellis MS, Kasper ZA. Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis. Am J Public Health. 2020;110(2):244\u201350.","journal-title":"Am J Public Health"},{"issue":"1","key":"746_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/tropicalmed10010017","volume":"10","author":"TJ Stopka","year":"2025","unstructured":"Stopka TJ, Nance RM, Mixson LS, Spencer H, Tsui JI, Leahy JM, et al. Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics? Trop Med Infect Disease. 2025;10(1):17.","journal-title":"Trop Med Infect Disease"},{"issue":"4","key":"746_CR3","doi-asserted-by":"publisher","first-page":"ofz089","DOI":"10.1093\/ofid\/ofz089","volume":"6","author":"PA Leahey","year":"2019","unstructured":"Leahey PA, LaSalvia MT, Rosenthal ES, Karchmer AW, Rowley CF. High Morbidity and Mortality Among Patients With Sentinel Admission for Injection Drug Use-Related Infective Endocarditis. Open Forum Infect Dis. 2019;6(4):ofz089.","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"746_CR4","first-page":"e6516","volume":"11","author":"M Ndanga","year":"2019","unstructured":"Ndanga M, Srinivasan S. Analysis of Hospitalization Length of Stay and Total Charges for Patients with Drug Abuse Comorbidity. Cureus. 2019;11(12):e6516.","journal-title":"Cureus"},{"issue":"1","key":"746_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70.","journal-title":"Harm Reduct J"},{"key":"746_CR6","unstructured":"Safe. Spot Overdose Hotline."},{"issue":"4","key":"746_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2105\/AJPH.2024.307583","volume":"114","author":"SN Facente","year":"2024","unstructured":"Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, et al. Funding and delivery of syringe services programs in the United States, 2022. Am J Public Health. 2024;114(4):435\u201343.","journal-title":"Am J Public Health"},{"issue":"9","key":"746_CR8","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1007\/s11606-024-08693-y","volume":"39","author":"M Hawk","year":"2024","unstructured":"Hawk M, Kay ES, Jawa R. Relational Harm Reduction for Internists: A Call to Action. J Gen Intern Med. 2024;39(9):1746\u20138.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"746_CR9","doi-asserted-by":"publisher","first-page":"e237888","DOI":"10.1001\/jamanetworkopen.2023.7888","volume":"6","author":"R Jawa","year":"2023","unstructured":"Jawa R, Tin Y, Nall S, Calcaterra SL, Savinkina A, Marks LR, et al. Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Netw Open. 2023;6(4):e237888.","journal-title":"JAMA Netw Open"},{"issue":"1suppl","key":"746_CR10","doi-asserted-by":"publisher","first-page":"s128","DOI":"10.1177\/0033354920921817","volume":"135","author":"MH Fern\u00e1ndez-Vi\u00f1a","year":"2020","unstructured":"Fern\u00e1ndez-Vi\u00f1a MH, Prood NE, Herpolsheimer A, Waimberg J, Burris S. State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014\u20132019. Public Health Rep. 2020;135(1suppl):s128\u201337.","journal-title":"Public Health Rep"},{"issue":"1","key":"746_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13722-023-00394-x","volume":"18","author":"A Jakubowski","year":"2023","unstructured":"Jakubowski A, Fowler S, Fox AD. Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature. Addict Sci Clin Pract. 2023;18(1):40.","journal-title":"Addict Sci Clin Pract"},{"issue":"5","key":"746_CR12","doi-asserted-by":"publisher","first-page":"e1002312","DOI":"10.1371\/journal.pmed.1002312","volume":"14","author":"CL Bernard","year":"2017","unstructured":"Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis. PLoS Med. 2017;14(5):e1002312.","journal-title":"PLoS Med"},{"key":"746_CR13","unstructured":"ONDCP. Actions taken by the Biden-Harris Administration to address addiction and the overdose epidemic. 2022. Available from. https:\/\/www.whitehouse.gov\/ondcp\/briefing-room\/2022\/08\/31\/actions-taken-by-the-biden-harris-administration-to-address-addiction-and-the-overdose-epidemic\/"},{"issue":"12","key":"746_CR14","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1007\/s11606-021-06904-4","volume":"36","author":"JL Taylor","year":"2021","unstructured":"Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings: Harm Reduction in Outpatient Addiction Treatment. J Gen Intern Med. 2021;36(12):3810\u20139.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"746_CR15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2105\/AJPH.2018.304600","volume":"108","author":"M Miskovic","year":"2018","unstructured":"Miskovic M, Chan Carusone S, Guta A, O\u2019Leary B, dePrinse K, Strike C. Distribution of Harm Reduction Kits in a Specialty HIV Hospital. Am J Public Health. 2018;108(10):1363\u20135.","journal-title":"Am J Public Health"},{"issue":"2","key":"746_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/00952990.2023.2169832","volume":"49","author":"Z Lindenfeld","year":"2023","unstructured":"Lindenfeld Z, Franz B, Cronin C, Chang JE. Hospital adoption of harm reduction and risk education strategies to address substance use disorders. Am J Drug Alcohol Abuse. 2023;49(2):206\u201315.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"746_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","volume":"41","author":"R Simon","year":"2020","unstructured":"Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus. 2020;41(4):519\u201325.","journal-title":"Subst Abus"},{"issue":"1","key":"746_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-024-00955-6","volume":"21","author":"JG Rosen","year":"2024","unstructured":"Rosen JG, Thompson E, Tardif J, Collins AB, Marshall BDL, Park JN. Make yourself un-NIMBY-able: stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America. Harm Reduct J. 2024;21(1):40.","journal-title":"Harm Reduct J"},{"key":"746_CR19","doi-asserted-by":"publisher","first-page":"102110","DOI":"10.1016\/j.cpr.2021.102110","volume":"91","author":"CE Paquette","year":"2022","unstructured":"Paquette CE, Daughters SB, Witkiewitz K. Expanding the continuum of substance use disorder treatment: Nonabstinence approaches. Clin Psychol Rev. 2022;91:102110.","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"746_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G","volume":"23","author":"M Sandelowski","year":"2000","unstructured":"Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334\u201340.","journal-title":"Res Nurs Health"},{"issue":"1","key":"746_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/nur.21768","volume":"40","author":"H Kim","year":"2017","unstructured":"Kim H, Sefcik JS, Bradway C. Characteristics of Qualitative Descriptive Studies: A Systematic Review. Res Nurs Health. 2017;40(1):23\u201342.","journal-title":"Res Nurs Health"},{"issue":"1","key":"746_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13012-021-01181-5","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Opra Widerquist MA, Lowery J. Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum. Implement Sci. 2022;17(1):7.","journal-title":"Implement Sci"},{"key":"746_CR23","unstructured":"Alaigh P. Pennsylvania\u2019s novel public-private approach to combatting the opioid crisis. NEJM Catalyst Innovations in Care Delivery [Internet]. 2020."},{"issue":"1","key":"746_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12954-023-00897-5","volume":"20","author":"M Shang","year":"2023","unstructured":"Shang M, Thiel B, Liebschutz JM, Kraemer KL, Freund A, Jawa R. Implementing harm reduction kits in an office-based addiction treatment program. Harm Reduct J. 2023;20(1):163.","journal-title":"Harm Reduct J"},{"issue":"1","key":"746_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13012-025-01450-7","volume":"20","author":"CM Reardon","year":"2025","unstructured":"Reardon CM, Damschroder LJ, Ashcraft LE, Kerins C, Bachrach RL, Nevedal AL, et al. The Consolidated Framework for Implementation Research (CFIR) User Guide: a five-step guide for conducting implementation research using the framework. Implement Sci. 2025;20(1):39.","journal-title":"Implement Sci"},{"issue":"9","key":"746_CR26","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res"},{"issue":"2","key":"746_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"key":"746_CR28","unstructured":"Greenland S, editor. Evolution of epidemiologic ideas: annotated readings on concepts and methods. Chestnut Hill (MA): Epidemiology Resources; 1987. p. 108\u2013110."},{"key":"746_CR29","doi-asserted-by":"publisher","first-page":"1113891","DOI":"10.3389\/frhs.2023.1113891","volume":"3","author":"C Forchuk","year":"2023","unstructured":"Forchuk C, Serrato J, Scott L. Identifying barriers and facilitators for implementing harm reduction strategies for methamphetamine use into hospital settings. Front Health Serv. 2023;3:1113891.","journal-title":"Front Health Serv"},{"key":"746_CR30","doi-asserted-by":"publisher","first-page":"1083042","DOI":"10.3389\/fpsyt.2022.1083042","volume":"13","author":"JC Sapag","year":"2022","unstructured":"Sapag JC, Traub C, Velasco PR, Arratia T, Alvarado R, Aracena M, et al. Reducing stigma toward mental illness and substance use issues in primary health care in Chile: Protocol of a cluster controlled trial study. Front Psychiatry. 2022;13:1083042.","journal-title":"Front Psychiatry"},{"key":"746_CR31","doi-asserted-by":"publisher","first-page":"103080","DOI":"10.1016\/j.drugpo.2020.103080","volume":"90","author":"E Childs","year":"2021","unstructured":"Childs E, Biello KB, Valente PK, Salhaney P, Biancarelli DL, Olson J, et al. Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies. Int J Drug Policy. 2021;90:103080.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"746_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11524-023-00717-y","volume":"100","author":"RE Giglio","year":"2023","unstructured":"Giglio RE, Mantha S, Harocopos A, Saha N, Reilly J, Cipriano C, et al. The Nation\u2019s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City. J Urban Health. 2023;100(2):245\u201354.","journal-title":"J Urban Health"},{"issue":"2","key":"746_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/00952990.2023.2169832","volume":"49","author":"Z Lindenfeld","year":"2023","unstructured":"Lindenfeld Z, Franz B, Cronin C, Chang JE. Hospital adoption of harm reduction and risk education strategies to address substance use disorders. Am J Drug Alcohol Abus. 2023;49(2):206\u201315.","journal-title":"Am J Drug Alcohol Abus"},{"issue":"1","key":"746_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1186\/s12909-023-04931-9","volume":"23","author":"KR Smith","year":"2023","unstructured":"Smith KR, Shah NK, Adamczyk AL, Weinstein LC, Kelly EL. Harm reduction in undergraduate and graduate medical education: a systematic scoping review. BMC Med Educ. 2023;23(1):986.","journal-title":"BMC Med Educ"},{"issue":"1","key":"746_CR35","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1080\/08897077.2022.2060423","volume":"43","author":"E Gugala","year":"2022","unstructured":"Gugala E, Briggs O, Moczygemba LR, Brown CM, Hill LG. Opioid harm reduction: A scoping review of physician and system-level gaps in knowledge, education, and practice. Subst Abus. 2022;43(1):972\u201387.","journal-title":"Subst Abus"},{"issue":"1","key":"746_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12954-018-0262-6","volume":"15","author":"LR Mahon","year":"2018","unstructured":"Mahon LR, Hawthorne AN, Lee J, Blue H, Palombi L. Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction. Harm Reduct J. 2018;15(1):57.","journal-title":"Harm Reduct J"},{"key":"746_CR37","doi-asserted-by":"publisher","unstructured":"Whitney E, Weyer G, Perri M, Dickson S, Kerins A, Landi AJ, et al. Understanding clinician knowledge, attitudes, and practices relating to nonpharmaceutical fentanyl and harm reduction. Subst Use Addctn J. 2025;46(1):120\u20136. https:\/\/doi.org\/10.1177\/29767342241266421. Epub 2024 Aug 1. PMID: 39087695.","DOI":"10.1177\/29767342241266421"},{"issue":"4","key":"746_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ADM.0b013e31821dc61a","volume":"5","author":"S Deren","year":"2011","unstructured":"Deren S, Kang SY, Mino M, Seewald RM. Attitudes of methadone program staff toward provision of harm-reduction and other services. J Addict Med. 2011;5(4):289\u201392.","journal-title":"J Addict Med"},{"issue":"12","key":"746_CR39","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s11606-023-08116-4","volume":"38","author":"PE Ackland","year":"2023","unstructured":"Ackland PE, Kenny ME, Clothier BA, Salameh HA, Boening N, Gordon AJ, et al. What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. J Gen Intern Med. 2023;38(12):2647\u201354.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"746_CR40","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.5811\/WESTJEM.59477","volume":"24","author":"ML Myles","year":"2023","unstructured":"Myles ML, Scott K, Ziobrowski HN, Helseth SA, Becker S, Samuels EA. Emergency Department Buprenorphine Quality Improvement and Emergency Physician Knowledge, Attitudes, and Self-Efficacy. West J Emerg Med. 2023;24(6):1005\u20139.","journal-title":"West J Emerg Med"},{"key":"746_CR41","unstructured":"US Department of Health and Human Services. Contingency management for the treatment of substance use disorders: enhancing access, quality, and program integrity for an evidence-based intervention. 2023."},{"key":"746_CR42","doi-asserted-by":"publisher","first-page":"112990","DOI":"10.1016\/j.drugalcdep.2025.112990","volume":"278","author":"A Markus","year":"2026","unstructured":"Markus A, Shang M, Studnicki O, Freund A, Merlin J, Liebschutz JM, et al. Micro-costing analysis of harm reduction services in office-based addiction treatment. Drug Alcohol Depend. 2026;278:112990.","journal-title":"Drug Alcohol Depend"},{"key":"746_CR43","doi-asserted-by":"crossref","unstructured":"Doe-Simkins M, Wheeler EJ, Figgatt MC, Jones TS, Bell A, Davidson PJ, et al. Naloxone Buyers Club: overlooked critical public health infrastructure for preventing overdose deaths. medRxiv. 2021:2021.11.14.21266221.","DOI":"10.1101\/2021.11.14.21266221"},{"issue":"4","key":"746_CR44","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","volume":"9","author":"E Oru","year":"2021","unstructured":"Oru E, Trickey A, Shirali R, Kanters S, Easterbrook P. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Lancet Glob Health. 2021;9(4):e431\u201345.","journal-title":"Lancet Glob Health"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-026-00746-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00746-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00746-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:06:44Z","timestamp":1790255204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13011-026-00746-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1186\/s13011-026-00746-1","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the University of Pittsburgh institutional review board and all focus group participants provided informed consent prior to participation.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and approved the final manuscript and consent for manuscript publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"61"}}